A French-led international medicines programme will soon begin buying recently developed Aids drugs from low-cost generic manufacturers in a move that may trigger clashes with western pharmaceutical companies holding the patents.
Countries supporting Unit-aid, the drugs purchasing facility for the developing world proposed by President Jacques Chirac, have agreed to give top priority to purchasing paediatric and second-line anti-retroviral medicines for HIV patients.
